These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 11166921)

  • 21. Evidence for three tumor suppressor loci on chromosome 9p involved in melanoma development.
    Pollock PM; Welch J; Hayward NK
    Cancer Res; 2001 Feb; 61(3):1154-61. PubMed ID: 11221846
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Copy number of the Adenomatous Polyposis Coli gene is not always neutral in sporadic colorectal cancers with loss of heterozygosity for the gene.
    Zauber P; Marotta S; Sabbath-Solitare M
    BMC Cancer; 2016 Mar; 16():213. PubMed ID: 26970738
    [TBL] [Abstract][Full Text] [Related]  

  • 23. P53 mutations in colorectal cancer assessed in both genomic DNA and cDNA as compared to the presence of p53 LOH.
    Forslund A; Kressner U; Lönnroth C; Andersson M; Lindmark G; Lundholm K
    Int J Oncol; 2002 Aug; 21(2):409-15. PubMed ID: 12118339
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Loss of heterozygosity of 14q32 in colorectal carcinoma.
    Bando T; Kato Y; Ihara Y; Yamagishi F; Tsukada K; Isobe M
    Cancer Genet Cytogenet; 1999 Jun; 111(2):161-5. PubMed ID: 10347556
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intratumor genetic heterogeneity in advanced human colorectal adenocarcinoma.
    Baisse B; Bouzourene H; Saraga EP; Bosman FT; Benhattar J
    Int J Cancer; 2001 Aug; 93(3):346-52. PubMed ID: 11433398
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of MYH polymorphisms in sporadic colorectal cancer in China: a case-control, population-based study.
    Yang L; Huang XE; Xu L; Zhou JN; Yu DS; Zhou X; Li DZ; Guan X
    Asian Pac J Cancer Prev; 2013; 14(11):6403-9. PubMed ID: 24377541
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mutational analysis of the transforming growth factor beta receptor type II gene in hereditary nonpolyposis colorectal cancer and early-onset colorectal cancer patients.
    Shin KH; Park YJ; Park JG
    Clin Cancer Res; 2000 Feb; 6(2):536-40. PubMed ID: 10690536
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Allelic deletions at chromosome 11q22-q23.1 and 11q25-qterm are frequent in sporadic breast but not colorectal cancers.
    Koreth J; Bakkenist CJ; McGee JO
    Oncogene; 1997 Jan; 14(4):431-7. PubMed ID: 9053840
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analysis of the transcription regulator, CNOT7, as a candidate chromosome 8 tumor suppressor gene in colorectal cancer.
    Flanagan J; Healey S; Young J; Whitehall V; Chenevix-Trench G
    Int J Cancer; 2003 Sep; 106(4):505-509. PubMed ID: 12845644
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oncogenic pathway of sporadic colorectal cancer with novel germline missense mutations in the hMSH2 gene.
    Yamada K; Zhong X; Kanazawa S; Koike J; Tsujita K; Hemmi H
    Oncol Rep; 2003; 10(4):859-66. PubMed ID: 12792735
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Absence of frequent involvement of modifier of Min(APC) in sporadic colorectal cancer.
    Kahlenberg MS; Stoler DL; Petrelli NJ; Rodriguez-Bigas M; Weber TK; Anderson GR
    Ann Surg Oncol; 1998 Mar; 5(2):181-5. PubMed ID: 9527272
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Polymorphism and allelic loss at the AS3 locus on 13q12-13 in esophageal squamous cell carcinoma.
    Harada H; Uchida N; Shimada Y; Kumimoto H; Shinoda M; Imamura M; Ishizaki K
    Int J Oncol; 2001 May; 18(5):1003-7. PubMed ID: 11295048
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Infrequent mutations of the activating transcription factor-2 gene in human lung cancer, neuroblastoma and breast cancer.
    Woo IS; Kohno T; Inoue K; Ishii S; Yokota J
    Int J Oncol; 2002 Mar; 20(3):527-31. PubMed ID: 11836564
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A comparison of the genetic pathways involved in the pathogenesis of three types of colorectal cancer.
    Tomlinson I; Ilyas M; Johnson V; Davies A; Clark G; Talbot I; Bodmer W
    J Pathol; 1998 Feb; 184(2):148-52. PubMed ID: 9602705
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Loss of heterozygosity in human aberrant crypt foci (ACF), a putative precursor of colon cancer.
    Luo L; Shen GQ; Stiffler KA; Wang QK; Pretlow TG; Pretlow TP
    Carcinogenesis; 2006 Jun; 27(6):1153-9. PubMed ID: 16474178
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mass spectrometry-based loss of heterozygosity analysis of single-nucleotide polymorphism loci in paraffin embedded tumors using the MassEXTEND assay: single-nucleotide polymorphism loss of heterozygosity analysis of the protein tyrosine phosphatase receptor type J in familial colorectal cancer.
    van Puijenbroek M; Dierssen JW; Stanssens P; van Eijk R; Cleton-Jansen AM; van Wezel T; Morreau H
    J Mol Diagn; 2005 Nov; 7(5):623-30. PubMed ID: 16258161
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Frequent deletion and down-regulation of ING4, a candidate tumor suppressor gene at 12p13, in head and neck squamous cell carcinomas.
    Gunduz M; Nagatsuka H; Demircan K; Gunduz E; Cengiz B; Ouchida M; Tsujigiwa H; Yamachika E; Fukushima K; Beder L; Hirohata S; Ninomiya Y; Nishizaki K; Shimizu K; Nagai N
    Gene; 2005 Aug; 356():109-17. PubMed ID: 15935570
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chromosome 10 and 17 deletions and p53 gene mutations in Thai patients with astrocytomas.
    Put-Ti-Noi S; Petmitr S; Chanyavanich V; Sangruji T; Theerapuncharoen V; Hayashi K; Thangnipon W
    Oncol Rep; 2004 Jan; 11(1):207-11. PubMed ID: 14654927
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Is the gene encoding Chibby implicated as a tumour suppressor in colorectal cancer ?
    Gad S; Teboul D; Lièvre A; Goasguen N; Berger A; Beaune P; Laurent-Puig P
    BMC Cancer; 2004 Jul; 4():31. PubMed ID: 15245581
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genomic organization and chromosomal localization of the human CUL2 gene and the role of von Hippel-Lindau tumor suppressor-binding protein (CUL2 and VBP1) mutation and loss in renal-cell carcinoma development.
    Clifford SC; Walsh S; Hewson K; Green EK; Brinke A; Green PM; Gianelli F; Eng C; Maher ER
    Genes Chromosomes Cancer; 1999 Sep; 26(1):20-8. PubMed ID: 10441001
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.